Literature DB >> 21468126

Viral hepatitis: Treating hepatitis C in children: an open horizon.

Maria Guido1, Flavia Bortolotti.   

Abstract

Most children with chronic hepatitis C have minimal liver disease before adulthood, but could be at risk of progression to cirrhosis and hepatocellular carcinoma because of persistent virus replication. The results of the first controlled trial with PEG-IFN-α2a plus ribavirin are a step towards an appropriate treatment for these children.

Entities:  

Year:  2011        PMID： 21468126     DOI： 10.1038/nrgastro.2011.61

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  10 in total

1.  The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.

Authors:  Kathleen B Schwarz; Regino P Gonzalez-Peralta; Karen F Murray; Jean P Molleston; Barbara A Haber; Maureen M Jonas; Philip Rosenthal; Parvathi Mohan; William F Balistreri; Michael R Narkewicz; Lesley Smith; Steven J Lobritto; Stephen Rossi; Alexandra Valsamakis; Zachary Goodman; Patricia R Robuck; Bruce A Barton
Journal:  Gastroenterology       Date:  2010-10-28       Impact factor: 22.682

2.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

3.  High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.

Authors:  Stefan Wirth; Carmen Ribes-Koninckx; Maria Angeles Calzado; Flavia Bortolotti; Lucia Zancan; Paloma Jara; Mark Shelton; Nanda Kerkar; Marcela Galoppo; Alejandra Pedreira; Norberto Rodriguez-Baez; Mirta Ciocca; Alain Lachaux; Florence Lacaille; Thomas Lang; Ulrike Kullmer; Wolf Dietrich Huber; Teresita Gonzalez; Henry Pollack; Estella Alonso; Pierre Broue; Jyoti Ramakrishna; Deborah Neigut; Antonio Del Valle-Segarra; Bessie Hunter; Zachery Goodman; Christine R Xu; Hanzhe Zheng; Stephanie Noviello; Vilma Sniukiene; Clifford Brass; Janice K Albrecht
Journal:  J Hepatol       Date:  2010-02-04       Impact factor: 25.083

4.  Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period.

Authors:  Flavia Bortolotti; Raffaele Iorio; Raffaele Jorio; Massimo Resti; Calogero Cammà; Matilde Marcellini; Raffaella Giacchino; Maria Grazia Marazzi; Gabriella Verucchi; Lucia Zancan; Cristiana Barbera; Giuseppe Maggiore; Pietro Vajro; Antonietta Giannattasio; Samuela Bartolacci
Journal:  J Hepatol       Date:  2007-01-26       Impact factor: 25.083

Review 5.  IL28B and the control of hepatitis C virus infection.

Authors:  Ashwin Balagopal; David L Thomas; Chloe L Thio
Journal:  Gastroenterology       Date:  2010-10-13       Impact factor: 22.682

Review 6.  Treatment of hepatitis C in children: a systematic review.

Authors:  Jia Hu; Karen Doucette; Lisa Hartling; Lisa Tjosvold; Joan Robinson
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

7.  Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

Authors:  Zachary D Goodman; Hala R Makhlouf; Lea Liu; William Balistreri; Regino P Gonzalez-Peralta; Barbara Haber; Maureen M Jonas; Parvathi Mohan; Jean P Molleston; Karen F Murray; Michael R Narkewicz; Philip Rosenthal; Lesley J Smith; Patricia R Robuck; Kathleen B Schwarz
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

8.  Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease.

Authors:  Flavia Bortolotti; Gabriella Verucchi; Calogero Cammà; Giuseppe Cabibbo; Lucia Zancan; Giuseppe Indolfi; Raffaella Giacchino; Matilde Marcellini; Maria Grazia Marazzi; Cristiana Barbera; Giuseppe Maggiore; Pietro Vajro; Samuela Bartolacci; Fiorella Balli; Anna Maccabruni; Maria Guido
Journal:  Gastroenterology       Date:  2008-03-02       Impact factor: 22.682

9.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

10.  Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?

Authors:  Maria Guido; Flavia Bortolotti; Gioacchino Leandro; Paloma Jara; Loreto Hierro; Javier Larrauri; Cristiana Barbera; Raffaella Giacchino; Lucia Zancan; Fiorella Balli; Carlo Crivellaro; Emilio Cristina; Angela Pucci; Massimo Rugge
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.